Dr. Cham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
Fl 6
San Francisco, CA 94143Phone+1 415-353-9600
Summary
- Dr. Stephanie Cham is an obstetrician/gynecologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center, Kaiser Permanente San Francisco Medical Center, and Kaiser Permanente San Francisco Medical Center. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 4 years. She specializes in gynecologic oncology. She has more than 10 publications and over 250 citings.
Education & Training
Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2019
New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2016 - 2019
David Geffen School of Medicine at UCLAClass of 2015
Certifications & Licensure
CA State Medical License 2022 - 2026
MA State Medical License 2019 - 2023- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholders.Stephanie Cham, Rachel A Pozzar, Neil Horowitz, Colleen Feltmate, Ursula A Matulonis
Journal of Geriatric Oncology. 2024-12-20 - Fragmented Surgical Cancer Care-A Growing Divide.Stephanie Cham, Jason Wright
JCO Oncology Practice. 2024-12-01 - 16 citationsUse of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance.Stephanie Cham, Mary Beth Landrum, Nancy L Keating, Joanne Armstrong, Alexi A Wright
JAMA Network Open. 2022-01-04
Press Mentions
BRCA Testing Is Not Widely Used in Women with Ovarian CancerJanuary 14th, 2022- BRCA Testing Underused in Women with Ovarian CancerJanuary 14th, 2022
- Germline BRCA Testing Underutilized in Ovarian CancerOctober 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
